Cartela (Rights to Develop New Drug to Treat Osteoarthritis) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Cartela (Rights to Develop New Drug to Treat Osteoarthritis) General Information
Description
Portfolio of rights to develop an antibody-based drug to treat osteoarthritis.
Contact Information
Corporate Office
- Lund
- Sweden
Corporate Office
- Lund
- Sweden
Cartela (Rights to Develop New Drug to Treat Osteoarthritis) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Cartela (Rights to Develop New Drug to Treat Osteoarthritis) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Cartela (Rights to Develop New Drug to Treat Osteoarthritis) FAQs
-
Where is Cartela (Rights to Develop New Drug to Treat Osteoarthritis) headquartered?
Cartela (Rights to Develop New Drug to Treat Osteoarthritis) is headquartered in Lund, Sweden.
-
What industry is Cartela (Rights to Develop New Drug to Treat Osteoarthritis) in?
Cartela (Rights to Develop New Drug to Treat Osteoarthritis)’s primary industry is Buildings and Property.
-
Is Cartela (Rights to Develop New Drug to Treat Osteoarthritis) a private or public company?
Cartela (Rights to Develop New Drug to Treat Osteoarthritis) is a Private company.
-
What is Cartela (Rights to Develop New Drug to Treat Osteoarthritis)’s current revenue?
The current revenue for Cartela (Rights to Develop New Drug to Treat Osteoarthritis) is .
-
Who are Cartela (Rights to Develop New Drug to Treat Osteoarthritis)’s investors?
Cartela has invested in Cartela (Rights to Develop New Drug to Treat Osteoarthritis).
-
When was Cartela (Rights to Develop New Drug to Treat Osteoarthritis) acquired?
Cartela (Rights to Develop New Drug to Treat Osteoarthritis) was acquired on 16-Oct-2003.
-
Who acquired Cartela (Rights to Develop New Drug to Treat Osteoarthritis)?
Cartela (Rights to Develop New Drug to Treat Osteoarthritis) was acquired by BioInvent International.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process